UBS Assumes Inspire Medical Systems at Sell, Lowers Price Target of $39
UBS analyst Patrick Wood assumes Inspire Medical Systems (NYSE:INSP) with a Sell rating and lowers Price Target of $39.
A big bank's expert said Inspire Medical might not be a great investment right now and lowered how much they think the stock is worth. This means the expert thinks the company might face challenges ahead, so it's worth watching what Inspire does next.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.